Login

Fullsix Unveils Diverse Pepper Solutions Across Retail, Banking, Hospitality, and Healthcare | Francesco Meani , CEO at Fullsix Spa 00:10:00

Share On Facebook Share On Twitter

Francesco Meani is the CEO at Fullsix Spa

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The Mutual Benefits of Paid Internships: Featuring Daniel Yerger on XYPN Radio | Daniel Yerger - President of MY Wealth Planners
00:10:00
Troy Von Haen on Fee-Only, Holistic Financial Planning and Finding Your 'It'
00:10:00
Caverion's Operational Performance Strengthened Towards Year-End: CEO Comments on inderesTV | Jacob Götzsche - CEO of Caverion
00:10:00
First Class Metals: Diverse Mineral Exploration in Northwestern Ontario
00:10:00
Exploring the Future of Cellular Agriculture: Innovations, Implications, and Supermarket Shelves|Jim Mellon, CEO, Agronomics Ltd .
00:10:00
Air Canada CEO Criticized for French Language Skills | Michael Rousseau, CEO, Air Canada.
00:10:00
BoxGroup is an early-stage investment fund that invests in technology companies|David Tisch,Managing Partner,BoxGroup
00:10:00
Strategic Growth and Transformation at Standard Chartered | Bill Winters, CEO, Standard Chartered.
00:10:00
Kevin Ford: Leading Calian Group Ltd. | Kevin Ford - CEO of Calian Group Ltd.
00:00:00
Satyajit T. Reddy, M.D. Cardiologist, Mayo Clinic
00:00:00
Proteomics International focused on first commercial sales for PromarkerD in USA - Dr Richard Lipscombe, MD, Proteomics International Laboratories Ltd
00:10:00
Brookfield's Bruce Flatt and Oaktree's Howard Marks on Strategic Acquisition for Credit Expansion

© 2017 - Neuhu+